From: Distinct serum metabolomics profiles associated with malignant progression in the KrasG12Dmouse model of pancreatic ductal adenocarcinoma
Age Group
Pancreatic Pathology
Genotype
n
3-5 months
PanIN 1 and 2
KrasG12D
17
normal
Wildtype
39
13-16 months
PanIN 2 and 3
11
wildtype
16
PDAC
3